Active Ingredient
Salicylic acid 17% W/V
The following Structured Product Label (SPL) was submitted to the FDA by Wenzhou Yuyuan Pharmaceutical Co., Ltd. for the product Xbofpen Wart Remover (NDC 87786-008). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using, stop use, ask doctor, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Salicylic acid 17% W/V
Wart remover
• for the removal of common and plantar warts
• the common wart is easily recognized by the rough “cauliflower-like” appearance on the surface.
• the plantar wart is recognized by its location only on the bottom of the foot, its tenderness and interruption of the footprint pattern
For external use only.
Keep away from fire and flame.
•on irritated skin or on any area that is infected or reddened
• on moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes.
• if you have diabetes or poor blood circulation.
• avoid contact with eyes. If product gets into the eyes, flush with water for 15 minutes.
• avoid inhaling vapors
• cap tightly and store at room temperature away from heat
Stop use and ask a doctor if discomfort persists.
Stop use and ask a doctor if discomfort persists.
If swallowed, get medical help or contact the Poison Control Center (1-800-222-1222) right away.
• wash affected area
• may soak wart in warm water for 5 minutes
• use a cotton swab to apply a sufficient amount to cover each wart. let it dry.
• repeat this procedure once or twice daily as needed (until wart is removed) for up to 12 weeks
• store at room temperature
• avoid excessive heat 37°C (99°F)
• skin discoloration may occur during or after use
Water, Borneol, Glycerin, Polyethylene Glycol.
* Please review the disclaimer below.